- Home
- MKDW vs APRE Comparison
MKDW vs APRE Comparison
Compare MKDW & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- APRE
- Stock Information
- Founded
- MKDW 2006
- APRE 2006
- Country
- MKDW Taiwan
- APRE United States
- Employees
- MKDW N/A
- APRE N/A
- Industry
- MKDW
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKDW
- APRE Health Care
- Exchange
- MKDW NYSE
- APRE Nasdaq
- Market Cap
- MKDW 15.4M
- APRE 15.8M
- IPO Year
- MKDW N/A
- APRE 2019
- Fundamental
- Price
- MKDW $0.89
- APRE $3.10
- Analyst Decision
- MKDW
- APRE Strong Buy
- Analyst Count
- MKDW 0
- APRE 2
- Target Price
- MKDW N/A
- APRE $15.50
- AVG Volume (30 Days)
- MKDW 1.1M
- APRE 21.7K
- Earning Date
- MKDW 12-24-2024
- APRE 11-07-2024
- Dividend Yield
- MKDW N/A
- APRE N/A
- EPS Growth
- MKDW N/A
- APRE N/A
- EPS
- MKDW N/A
- APRE N/A
- Revenue
- MKDW N/A
- APRE $1,310,839.00
- Revenue This Year
- MKDW N/A
- APRE $134.21
- Revenue Next Year
- MKDW N/A
- APRE N/A
- P/E Ratio
- MKDW N/A
- APRE N/A
- Revenue Growth
- MKDW N/A
- APRE 130.31
- 52 Week Low
- MKDW $0.47
- APRE $2.15
- 52 Week High
- MKDW $16.00
- APRE $8.85
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- APRE 47.02
- Support Level
- MKDW N/A
- APRE $3.08
- Resistance Level
- MKDW N/A
- APRE $3.39
- Average True Range (ATR)
- MKDW 0.00
- APRE 0.29
- MACD
- MKDW 0.00
- APRE 0.02
- Stochastic Oscillator
- MKDW 0.00
- APRE 38.12
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.